IISART (International Industry Society of Advanced Rehabilitation Technology) Advanced Rehabilitation Technology Study
Clinicians, Academics, Industry, and Insurance Collaborate to Assess Cost-Effectiveness and Functional Outcomes Using Advanced Rehabilitation Technology
1 other identifier
interventional
200
1 country
1
Brief Summary
A pre-post, randomized control trial comparing cost-effective and functional outcomes of participants with neurological diagnoses using robotic devices and advanced technology during inpatient rehabilitation to the outcomes of control participants without the use of robotic devices and advanced technology during rehabilitation. We aim to show at least similar inpatient rehabilitation outcomes and improved health economics in participants with neurological diagnoses by using robotic devices and advanced technology to increase the intensity and dose of rehabilitation.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Oct 2022
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 17, 2022
CompletedFirst Submitted
Initial submission to the registry
November 14, 2022
CompletedFirst Posted
Study publicly available on registry
December 15, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 17, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
January 17, 2025
CompletedDecember 15, 2022
December 1, 2022
2 years
November 14, 2022
December 7, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Neuro-QOL
Neuro-QOL battery: Ability to Participate in Social Roles and Activities, Satisfaction with Social Roles and Activities, Positive Affect and Well-Being
Through study completion, an average of 2 years
Secondary Outcomes (16)
Length of stay/# of visits
Through study completion, an average of 2 years
Total cost of care (TCOC)
Through study completion, an average of 2 years
Cost of caregiver burden
Through study completion, an average of 2 years
Discharge disposition
Through study completion, an average of 2 years
Return to work/school/volunteer
Through study completion, an average of 2 years
- +11 more secondary outcomes
Other Outcomes (1)
Goal attainment scale (GAS)
Through study completion, an average of 2 years
Study Arms (2)
Inpatient Rehabilitation with ART
EXPERIMENTALInpatient rehabilitation with advanced rehabilitation technology
Inpatient Rehabilitation without ART
ACTIVE COMPARATORInpatient rehabilitation without advanced rehabilitation technology
Interventions
Participants to receive at least 5 sessions with advanced rehabilitation technology including at least one, or multiple, of the following devices: Amadeo, Diego, Myro, Arm Motus EMU, Pelma Motus, Tigo, Balo, EKSO NR. Sessions are 45 (+/- 5) minutes
Standard inpatient rehabilitation therapy without advanced rehabilitation technology
Eligibility Criteria
You may qualify if:
- Currently admitted for inpatient rehabilitation at Rehabilitation Hospital Overland Park with neurological diagnosis.
- At least 18 years of age.
- Predicted length of stay to be at least 7 days.
- Able to tolerate upright sitting without orthostatic hypotension for upper extremity, cycling, and sitting balance devices AND/OR able to tolerate upright standing for at least 15 minutes without orthostatic hypotension for walking and standing balance devices.
- Able to fit into at least one device.
- Screened and cleared by a physician.
- Cognitively intact to communicate pain and/or need to stop session, and able to follow simple commands.
You may not qualify if:
- Current or history of other medical conditions that could affect the outcome measures.
- Currently involved in another intervention study.
- Any absolute contraindication listed for each device used.
- Any pre-existing physical or medical condition that the Physiatrist determines would significantly limit a patient's ability to benefit from or continue in the study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Rehabilitation Hospital of Overland Parklead
- Discovery Statisticscollaborator
Study Sites (1)
Rehabilitation Hospital of Overland Park
Overland Park, Kansas, 66207, United States
Related Publications (1)
Spiess MR, Steenbrink F, Esquenazi A. Getting the Best Out of Advanced Rehabilitation Technology for the Lower Limbs: Minding Motor Learning Principles. PM R. 2018 Sep;10(9 Suppl 2):S165-S173. doi: 10.1016/j.pmrj.2018.06.007.
PMID: 30269803BACKGROUND
MeSH Terms
Conditions
Study Officials
- PRINCIPAL INVESTIGATOR
Brett Schoen, MD
Rehabilitation Hospital of Overland Park
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- Masked/blinded outpatient therapists will perform outcome assessments.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Medical Director
Study Record Dates
First Submitted
November 14, 2022
First Posted
December 15, 2022
Study Start
October 17, 2022
Primary Completion
October 17, 2024
Study Completion
January 17, 2025
Last Updated
December 15, 2022
Record last verified: 2022-12
Data Sharing
- IPD Sharing
- Will not share